AOD 9604 5 mg

Dragon Pharma AOD 9604

For athletes, bodybuilders, and fitness enthusiasts seeking to understand the mechanisms of fat metabolism and body composition optimization, AOD 9604 represents a unique research tool. This synthetic peptide is a fragment of human growth hormone (hGH) corresponding to amino acids 177-191—the region responsible for the lipolytic (fat-burning) effects of growth hormone, without the associated effects on insulin-like growth factor-1 (IGF-1) or blood glucose. This Dragon Pharma AOD 9604 5mg offering delivers high-purity lyophilized powder in a sterile 2mL vial, providing researchers with a premium compound for advanced fat metabolism and body composition research.

AOD 9604 functions by mimicking the lipolytic activity of growth hormone, stimulating the breakdown of fat (lipolysis) and inhibiting fat synthesis (lipogenesis). Unlike full-length growth hormone, AOD 9604 does not bind to prolactin receptors and has minimal effect on IGF-1 or blood glucose levels, making it a more targeted tool for studying fat metabolism pathways. Research published in the NIH PubMed database demonstrates that AOD 9604 promotes fat oxidation, reduces body fat accumulation, and may support improvements in body composition without the unwanted side effects associated with full-length growth hormone administration.

The relevance of AOD 9604 to the athletic and bodybuilding community is significant. For athletes focused on achieving low body fat levels for competition, understanding the mechanisms of lipolysis is crucial. AOD 9604's targeted effect on fat metabolism offers a unique research tool for studying fat reduction independent of systemic growth hormone effects. Unlike compounds that work through appetite suppression or metabolic stimulation, AOD 9604 directly promotes the breakdown of stored fat, making it valuable for research into adipose tissue biology and body composition optimization. Additionally, its lack of effect on blood glucose makes it particularly interesting for research protocols where glucose homeostasis is a consideration.

Quality assurance is paramount in peptide research. Each batch of our AOD 9604 5 mg inventory undergoes rigorous third-party HPLC-MS testing to verify purity and dosage. Lab test documentation will be available shortly, reflecting Dragon Pharma's commitment to transparency and quality across all products.

For bodybuilders and strength athletes researching advanced body composition strategies, AOD 9604 offers a targeted approach to studying fat metabolism. Its specific mechanism of action—promoting lipolysis without affecting IGF-1 or glucose—makes it a valuable tool for investigating fat loss pathways independent of broader hormonal effects. Whether investigating strategies for adipose tissue reduction, metabolic conditioning, or body composition optimization, Dragon Pharma's AOD 9604 delivers the purity, potency, and reliability required for serious research into fat metabolism.

Note: This product is intended for laboratory research and scientific investigation purposes only. Not for human consumption or veterinary use.

Product Specifications

Usage Guidelines

AOD 9604 is supplied as a sterile lyophilized powder and must be reconstituted with bacteriostatic water prior to research use. For optimal stability, gently swirl the vial after adding the diluent—do not shake vigorously. Standard research protocols involve reconstituting the 5mg peptide with 2-4mL of bacteriostatic water, yielding a concentration of 1.25-2.5mg/mL. Typical research dosing ranges from 0.1-0.5mg per administration, often administered 1-2 times daily via subcutaneous injection. Due to its targeted lipolytic mechanism, dosing protocols vary based on research objectives. It is recommended to store the reconstituted peptide in a refrigerator (2-8°C) and use within 30 days to maintain peptide integrity.

For researchers investigating comprehensive body composition and metabolic protocols, combining AOD 9604 with complementary compounds can yield synergistic insights. Consider exploring the following Dragon Pharma products to enhance your research:

• AICAR: An AMPK activator studied alongside AOD 9604 for complementary effects on fat metabolism and energy homeostasis.
• L-Carnitine 500mg: Studied for its role in fatty acid oxidation during metabolic research protocols.
• GW501516: A PPARδ agonist for comparative research on fatty acid oxidation pathways.

Third-Party Lab Results

Shipping & Authenticity

• From USA Domestic warehouse: 2-5 business days.
• From International warehouse: 14-21 business days.
• Free and automatic re-shipping policy if package doesn't reach destination within 30 days.
• Original product directly from manufacturer.
• We accept credit cards and cryptocurrency—crypto payments receive an additional 20% discount at checkout.

Storage Instructions

To maintain maximum stability and potency of the lyophilized powder, store the unopened vial in a freezer at -20°C (-4°F) away from light. Upon reconstitution with bacteriostatic water, the solution must be stored in a refrigerator at 2-8°C (36-46°F) and should be used within 30 days. Avoid repeated freeze-thaw cycles as this may degrade the peptide structure.

Frequently Asked Questions